Dyslipidemia, subclinical inflammation, hepatic cholestasis and endothelial dysfunction in schoolchildren with excess fat: A study from the United Arab Emirates
Open Access
- 9 January 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (1) , e0210316
Abstract
The impact of obesity on cardiovascular health of young children is still to be fully illustrated. This study measured biomarkers for glycemic control, lipid metabolism, systemic inflammation, endothelial dysfunction, and hepatic cholestasis in schoolchildren. Its main purpose was to determine whether metabolic derangements could be detected in young children with excess fat. This cross-sectional study involved 967 children in the second, sixth, and tenth grades (median age, 7.3, 11.3, and 15.4 years, respectively). Using the International Obesity Task Force interpretation (IOTF) of body-mass-index (BMI), children were stratified as thin (th centiles), overweight (85th to th centiles), obese (95th to th centiles), or extremely-obese (≥98th centiles). Waist circumference was also measured. Several metabolic determinations were then used as surrogate biomarkers for cardiovascular risks. Prevalence of BMI≥85th centile among the second graders was 13.1%, sixth graders 42.2%, and tenth graders 33.8%. BMI≥85th centile was associated with a tendency for higher hemoglobin A1c (p≥0.160) and higher blood glucose (p≥0.197). For the second graders, BMI≥85th centile was associated with higher high-sensitivity C-reactive protein (hs-CRP, pppp≤0.024), and lower high-density lipoprotein (HDL, pth centile was associated with higher gamma-glutamyl transferase (GGT, pth centile was insignificantly changed with sICAM-1 or the soluble vascular cytoadhesive molecule-1 (sVCAM-1). The studied children with excess fat had increased risks for developing systemic inflammation, dyslipidemia, endothelial dysfunction, cholestasis, and diabetes. These results suggest that metabolic biomarkers should be included in the routine assessment of children with an overweight problem.Keywords
Funding Information
- Faculty Grant (research grant (31M257, 2016/2017) from the CMHS, UAE University)
This publication has 25 references indexed in Scilit:
- New Insight into Adiponectin Role in Obesity and Obesity-Related DiseasesBioMed Research International, 2014
- Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary ReportPediatrics, 2011
- Obesity as a Disease: A White Paper on Evidence and Arguments Commissioned by the Council of The Obesity SocietyObesity, 2008
- Development of a WHO growth reference for school-aged children and adolescents2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetesMetabolism, 2005
- Inflammation in atherosclerosisNature, 2002
- Plasma Adiponectin Concentrations in Children: Relationships with Obesity and InsulinemiaThe Journal of Clinical Endocrinology & Metabolism, 2002
- Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent PathwayCirculation, 2000
- Novel Modulator for Endothelial Adhesion MoleculesCirculation, 1999